Decline in FEV1 related to genetic polymorphisms (+138insA/delA and Lys198Asn) of the endothelin-1 gene in COPD. A pilot study

European Review for Medical and Pharmacological Sciences

Volumn 14, Issue 8, 2010, Pages 705-719

  Kaparianos, A ^a   Argyropoulou, E ^a   Efremidis, G ^a   Flordellis, C ^b   Spiropoulos, Kostas ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

COPD; Endothelin 1; FEV1; FEV1 decline; Polymorphisms

Indexed keywords

ENDOTHELIN 1;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOTE; HUMAN; INDEL MUTATION; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SPIROMETRY; TRANSCRIPTION INITIATION SITE; WILD TYPE; AGED; ALLELE; EXON; FOLLOW UP; GENETIC POLYMORPHISM; GENETICS; HOSPITALIZATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHENOTYPE; PILOT STUDY;

ADULT; AGED; ALLELES; ENDOTHELIN-1; EXONS; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PILOT PROJECTS; POLYMORPHISM, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SMOKING; SPIROMETRY;

EID: 77955956169     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. LOPEZ AD, MURRAY CC. The global burden of disease, 1990-2020. Nat Med 1998; 4: 1241-1243.
2. CHUNG KF, BARNES PJ. Cytokines in asthma. Thorax 1999; 54: 825-857.
3. MIYAUCHI T, MASAKI T. Pathophysiology of endothelin in the cardiovascular system. Annu Rev Physiol 1999; 61: 391-415.
4. BOSCOE MJ, GOODWIN AT, AMRANI M, YACOUB MH. Endothelins and the lung. Int J Biochem Cell Biol 2000; 32: 41-62.
5. ORTEGA MATEO A, DE ARTINANO AA. Highlights on endothelins. Pharmacol Res 1997; 36: 339-351.
6. MATSUMURA Y, IKEGAWA R, OHYAMA T, HAYASHI K, MORIMOTO S. Endothelin immunoreactivity in medium from cultured porcine aortic endothelial cells correlates with the biological activity. Biochem Biophys Res Commun 1989; 160: 602-608.
7. GIAID A, POLAK JM, GAITONDE V, HAMID QA, MOSCOSO G, LEGON S, UWANOGHO D, RONCALLI M, SHINMI O, SAWAMURA T, KIMURA S, YANAGISAWA M, MASAKI T, SPRINGALL DR. Distribution of endothelin-like immunoreactivity and mRNA in the developing and adult human lung. Am J Respir Cell Mol Biol 1991; 4: 50-58.
8. EHRENREICH H, ANDERSON RW, FOX CH, RIECKMANN P, HOFFMAN GS, TRAVIS WD, COLIGAN JE, KEHRL JH, FAUCI AS. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med 1990; 172: 1741-1748.
9. SESSA WC, KAW S, HECKER M, VANE JR. The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes. Biochem Biophys Res Commun 1991; 174: 613-618.
10. GU J, PINHEIRO JM, YU CZ, D'ANDREA M, MURAUDHARAN S, MAUK A. Detection of endothelin-like immunoreactivity in epithelium and fibroblasts of the human umbilical cord. Tissue Cell 1991; 23: 437-444.
11. YANAGISAWA M, KURIHARA H, KIMURA S, TOMOBE Y, KOBAYASHI M, MITSUI Y YAZAKI Y, GOTO K, MASAKI T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415.
12. ADVENIER C, SARRIA B, NALINE E, PUYBASSET L, LAGENTE V. Contractile activity of three endothelins (ET-1, ET-2 and ET-3) on the human isolated bronchus. Br J Pharmacol 1990; 100: 168-172.
13. SHIMURA S, ISHIHARA H, SATOH M, MASUDA T, NAGAKI N, SASAKI H, TAKISHIMA T. Endothelin regulation of mucus glycoprotein secretion from feline tracheal submucosal glands. Am J Physiol 1992; 262: L208-L213.
14. SIROIS MG, FILEP JG, ROUSSEAU A, FOURNIER A, PLANTE GE, SIROIS P. Endothelin-1 enhances vascular permeability in conscious rats: role of thromboxane A2. Eur J Pharmacol 1992; 214: 119-125.
15. FINSNES F, CHRISTENSEN G, LYBERG T, SEJERSTED OM, SKJONSBERG OH. Increased synthesis and release of endothelin-1 during the initial phase of airway inflammation. Am J Respir Crit Care Med 1998; 158: 1600-1606.
16. HOGG JC, CHU F, UTOKAPARCH S, WOODS R, ELLIOTT WM, BUZATU L, CHERNIACK RM, ROGERS RM, SCIURBA FC, COXSON HO, PARÉ PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2645-2653. (Pubitemid 38787999)
17. BACAKOGLU F, ATASEVER A, OZHAN MH, GURGUN C, OZKILIC H, GUZELANT A. Plasma and bronchoalveolar lavage fluid levels of endothelin-1 in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Respiration 2003; 70: 594-599.
18. ROLAND M, BHOWMIK A, SAPSFORD RJ, SEEMUNGAL TA, JEFFRIES DJ, WARNER TD, WEDZICHA JA. Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease. Thorax 2001; 56: 30-35.
19. TRAKADA G, MARANGOS M, SPIROPOULOS K. Mechanisms of endothelin-1 elevation in chronic obstructive pulmonary disease patients with nocturnal oxyhemoglobin desaturation. Respiration 2001; 68: 134-139.
20. SPIROPOULOS K, TRAKADA G, NIKOLAOU E, PRODROMAKIS E, EFREMIDIS G, POULI A, KONIAVITOU A. Endothelin-1 levels in the pathophysiology of chronic obstructive pulmonary disease and bronchial asthma. Respir Med 2003; 97: 983-989.
21. BLOOM JW, SUGIHARA S, GARFIELD MD, ABRAHAM TA, KNUDSON RJ. Characteristics of individuals with accelerated declines in lung function. Chest 1985; 6: 18S-19S.
22. BURCHFIEL CM, MARCUS EB, SHARP DS, ENRIGHT PL, RODRIGUEZ BL, MASAKI KH, HWANG LJ, CURB JD Characteristics associated with rapid decline in forced expiratory volumes. Ann Epidemiol 1996; 6: 217-227.
23. BURROWS B, LEBOWITZ MD, CAMILLI AE, KNUDSON RJ. Longitudinal changes in forced expiratory volume in one second in adults. Methodologic considerations and findings in healthy nonsmokers. Am Rev Respir Dis 1986; 133: 974-980.
24. INOUE A, YANAGISAWA M, TAKUWA Y, MITSUI Y, KOBAYASHI M, MASAKI T. The human preproendothelin-1 gene. Complete nucleotide sequence and regulation of expression. J Biol Chem 1989; 264: 14954-14959. (Pubitemid 19237323)
25. STEVENS PA, BROWN MJ. Genetic variability of the ET-1 and the ETA receptor genes in essential hypertension. J Cardiovasc Pharmacol 1995; 26(suppl 3): S9-S12.
26. POPOWSKI K, SPERKER B, KROEMER HK, JOHN U, LAULE M, STANGL K, CASCORBI I. Functional significance of a hereditary adenine insertion variant in the 5′-UTR of the endothelin-1 gene. Pharmacogenetics 2003; 13: 445-451.
27. BARDEN AE, HERBISON CE, BEILIN LJ, MICHAEL CA, WALTERS BN, VAN BOCKXMEER FM. Association between the endothelin-1 gene Lys198Asn polymorphism blood pressure and plasma endothelin-1 levels in normal and pre-eclamptic pregnancy. J Hypertens 2001; 19: 1775-1782.
28. AMERICAN THORACIC SOCIETY. Standardization of spirometry; 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
29. TIRET L, POIRIER O, HALLET V, MCDONAGH TA, MORRISON C, MCMURRAY JJ, DARGIE HJ, ARVEILER D, RUIDAVETS JB, LUC G, EVANS A, CAMBIEN F. The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 1999; 33: 1169-1174.
30. JIN JJ, NAKURA J, WU Z, YAMAMOTO M, ABE M, TABARA Y, YAMAMOTO Y, IGASE M, KOHARA K, MIKI T. Association of endothelin-1 gene variant with hypertension. Hypertension 2003; 41: 163-167.
31. TANAKA C, KAMIDE K, TAKIUCHI S, KAWANO Y, MIYATA T. Evaluation of the Lys198Asn and 134delA genetic polymorphisms of the endothelin-1 gene. Hypertens Res 2004; 27: 367-371.
32. LEVIN ER. Endothelins. N Engl J Med 1995; 333: 356-363.
33. HICKEY KA, RUBANYI GM, PAUL RJ, HIGHSMITH RF. Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. Am J Physiol 1985; 248: C550-C556.
34. BARANIUK JN, MOLET S, MULLOL J, NARANCH K. Endothelin and the airway mucosa. PuIm Pharmacol Ther 1998; 11: 113-123.
35. DINH-XUAN AT. Endothelial modulation of pulmonary vascular tone. Eur Respir J 1992; 5: 757-762.
36. ZIEGLER JW, IVY DD, KINSELLA JP, ABMAN SH. The role of nitric oxide, endothelin, and prostaglandins in the transition of the pulmonary circulation. Clin Perinatal 1995; 22: 387-403.
37. STEWART DJ, LEVY RD, CERNACEK P, LANGLEBEN D. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med 1991; 114: 464-469.
38. GOERRE S, WENK M, BARTSCH P, LUSCHER TF, NIROOMAND F, HOHENHAUS E, OELZ O, REINHART WH. Endothelin-1 in pulmonary hypertension associated with high-altitude exposure. Circulation 1995; 91: 359-364.
39. SITBON O, BRENOT F, DENJEAN A, BERGERON A, PARENT F, AZARIAN R, HERVE P, RAFFESTIN B, SIMONNEAU G. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. Am J Respir Crit Care Med 1995; 151(2 Pt 1): 384-389.
40. ZAPOL WM, RIMAR S, GILLIS N, MARLETTA M, BOSKEN CH. Nitric oxide and the lung. Am J Respir Crit Care Med 1994; 149: 1375-1380.